upon 20 February 2003 the FDA issue...

upon 20 February 2003 the FDA issued a of the present day draft guidance document on 21 CFR 11 that surprised many in the industry. The draft guidance incantations out a new, narrowed tendency to the interpretation of 21 CFR 11 the Electronic Records, Electronic Signatures control with an emphasis on a risk-based approach to 21 CFR 11 activities. To appreciate the implications of this change, it is worthwhile to explore a of the original basis of 21 CFR 11 which is fit clinical practice.

In 1974 during my sophomore year in college edifice [i]or[/i] building I found my scientific idealism shaken at its bases when the ...